- KR₩78bn
- KR₩103bn
- KR₩9bn
Annual balance sheet for Sun Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,526 | 6,549 | 11,068 | 5,753 | 6,195 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,052 | 3,468 | 3,841 | 4,928 | 4,235 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,399 | 11,416 | 16,112 | 12,259 | 12,569 |
| Net Property, Plant And Equipment | 4,362 | 8,055 | 26,534 | 35,148 | 48,449 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 17,772 | 19,720 | 42,899 | 47,663 | 61,017 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,497 | 2,717 | 18,035 | 18,740 | 17,494 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8,936 | 4,323 | 19,060 | 19,558 | 33,939 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 8,836 | 15,397 | 23,839 | 28,105 | 27,078 |
| Total Liabilities & Shareholders' Equity | 17,772 | 19,720 | 42,899 | 47,663 | 61,017 |
| Total Common Shares Outstanding |